Introduction The burden of disease resulting from neonatal conditions is substantial in developing countries. From 2003 to 2005, the Projahnmo I programme delivered community-based interventions for maternal and newborn health in Sylhet, Bangladesh. This analysis quantifies burden of disability and incorporates non-fatal outcomes into cost-effectiveness analysis of interventions delivered in the Projahnmo I programme.
Introduction
The World Health Organization (WHO) estimated that perinatal conditions were the 6th leading cause of disability in the developing world in 2001 (Mathers et al. 2006a) . About 3.575 million deaths worldwide occur annually during the neonatal period (Black et al. 2010) ; however, evidence is mixed on whether life-saving interventions increase population morbidity (Durkin et al. 2006; Winter et al. 2002; Boyle et al. 2011) , or if morbidity patterns will remain constant or improve with time (Platt et al. 2007; D'Amore et al. 2011; Jang et al. 2011; van Haastert et al. 2011) . Quantifying summary measures for population health for disabling conditions arising in the neonatal period is a key information gap in international public health (Azra Haider and Bhutta 2006; Maulik and Darmstadt 2007) , and more evidence is needed about their impact on the cost-effectiveness of community-based interventions Maulik and Darmstadt 2009) .
Three key categories of neonatal conditions that can cause disability include preterm birth, infections and intrapartumrelated hypoxia ('birth asphyxia'). Congenital anomalies, certainly associated with disability, have not yet been figured into our estimates due to methodological uncertainties given available data. Thirteen million or 9.6% of all births in low-and middle-income countries (LMICs) were preterm in 2005 (Beck et al. 2010) . Data from four high-mortality countries showed that 71/1000 live births had culture-confirmed infection; however, the proportion of neonates with community-acquired infection that were brought to health centres may have been affected by selection bias (WHO Young Infants Study Group 1999) . Clinical diagnosis suggests that 56-105/1000 newborns in South Asia have suspected serious infection depending on the algorithm used (Bang et al. 2005a; Baqui et al. 2009a) . A review of studies from LMICs reported neonatal infection incidence rates of 0.8-6.1/1000 for meningitis, 30-156/1000 for diarrhoea, 142/1000 for severe pneumonia and 201/1000 for acute respiratory infection (Thaver and Zaidi 2009) . Statistics on the incidence of viral infections are needed. Ten million neonates do not breathe immediately at birth, of which 6 million require resuscitation (Wall et al. 2009) , and 1-1.2 million infants develop severe sequelae from 'birth asphyxia' (Saving Newborn Lives 2001; WHO 2005) . In South Asia, 14-20% of newborns in community settings do not spontaneously initiate breathing (Bang et al. 2005b ; Lee et al. 2011a) .
Perinatal conditions lead to a variety of long-term neurological sequelae (Table 1a) . A community-based test of the Ten Questions screening survey among 2-to 9-year-old children in Bangladesh found that 69/1000 had mild or serious disability in cognition, hearing, motor skills, vision, or seizures (Khan and Durkin 1995) . Recent evidence from the Multiple Indicator Cluster Survey (MICS), a cross-sectional survey using the Ten Question Screen, estimated an incidence of disability in children 2-9 years old of 21% in Bangladesh (Gottlieb et al. 2009 ), although screening tools tend to overestimate compared with proper diagnostic instruments. As neonatal survival continues to improve in Bangladesh, the prevalence of learning and developmental disability may also be affected (Durkin et al. 2006) .
These figures are necessarily rough estimates. More than half of births are unattended in high mortality settings and between 80% to >90% of births take place at home in rural Bangladesh. Most do not receive postnatal care, restricting capacity to diagnose conditions promptly after birth (Darmstadt et al. 2009a) . In South Asia, 74% of newborn infants are not weighed (WHO 2004) , and a smaller proportion is of known gestational age. Only clinical diagnosis is available for infections in community-based settings, and incidence estimates are substantially higher than those based on laboratory-confirmed diagnosis (Darmstadt et al. 2009b) . Consensus has been difficult on definitions of 'birth asphyxia' (Nelson and Leviton 1991; Lawn et al. 2007; Lee et al. 2008; Halloran et al. 2009) , as highlighted in a recent article to clarify terminology for intrapartum-related outcomes (Lawn et al. 2009 ). Data on long-term morbidity and impairment from LMICs is scarce and inconsistent.
Disability-adjusted life years (DALYs) are currently the standard summary measure of population health used in LMICs (Murray and Lopez 1996) , and are commonly used in burden of disease and economic evaluation studies in international health. DALYs are composed of years of life lost (YLLs) due to premature mortality and years lost to disability (YLD) due to disease states of less-than-perfect health. To date, cost-effectiveness analyses of neonatal health interventions in LMICs have only included YLLs for neonates (Borghi et al. 2005; Darmstadt et al. 2005; Lefevre et al. 2010) . The only mention of neonatal morbidity in the second edition of the Disease Control Priorities Project (DCP2) indicates that data are scarce , and it is not clear how YLDs were calculated in WHO-CHOICE estimates (Adam et al. 2005) .
Data are becoming available to facilitate calculation of YLD to enhance the comparability of neonatal cost-effectiveness analyses to the spectrum of health care interventions relevant to LMICs. Long-term outcome studies are being published from Dhaka Shishu hospital (Khan et al. 2006; Saha et al. 2009 ), Global Burden of Disease (GBD) reviews have been conducted, and pooled estimates for input parameters are becoming available Watt et al. 2009; Edmond et al. 2010) . This article presents a model framework for calculating YLD resulting from neonatal conditions that can be easily applied to cost-effectiveness analysis of relevant interventions, with an example using data from the Projahnmo I trial from rural Sylhet, Bangladesh. Outputs are presented as YLD associated with a modelled comparison arm, YLD averted due to intervention, DALYs averted and incremental cost-effectiveness.
Methods

Analytical overview
Burden of YLD was modelled using a tree structure, with differences in YLD expected between study arms calculated in a decision tree framework (Figure 1 ). Costs and YLL were factored in to calculate incremental cost-effectiveness. Relevant neonatal conditions and disabling sequelae were included; 'birth asphyxia' values from the Australian Burden of Disease (ABD) study , meningitis values from meta-analysis (Edmond et al. 2010) , and preterm values from a relevant Bangladeshi study (Khan et al. 2006) . Low birth-weight (LBW) was replaced by preterm birth since preterm is a more specific predictor of disability and is consistent with current clinical paradigms and cause-of-death classification (Lawn et al. 2010) .
Data were checked for consistency and quality, and results were generated according to probabilities of different outcomes emanating from different health states according to nodes and branches within the tree framework (Figure 1) . To the extent possible, the intervention arm was parameterized using primary data from the home care arm of the Projahnmo I trial, using year 2005 to represent the programme at maturity (Table 2a ) (Baqui et al. 2008; Baqui et al. 2009a) . In the absence of data from the comparison arm of the trial (community health workers did not make home visits in that arm), the comparator arm was modelled assuming that all mortality reduction was due to averted infections. Variation around incremental survival and sequelae from infections was assumed to be 25%, similar to what is often observed in meta-analysis of very large trials (Table 2b) . Information gaps were modelled with data from published literature.
Study context
Intervention components for the Projahnmo I home care arm are described in a previous paper (Baqui et al. 2008) . Perinatal prevention and treatment interventions for newborn health were delivered through a partnership between a local non-governmental organization (Shimantik) and Johns Hopkins University in Sylhet, Bangladesh. An enhanced version of the WHO Essential Newborn Care training and package of interventions was provided, including pregnancy surveillance, birth preparedness, algorithm-based recognition of maternal and newborn illness by community health workers (CHWs) or families, referral and/or home treatment for sepsis, and continued monitoring and advice (if not severe). While resuscitation training was provided, bag and mask were not included as part of the intervention, and only 5% of deliveries were attended by CHWs. The study population included all births in Sylhet district, a setting with the highest neonatal mortality rate (48 deaths per 1000 live births at baseline survey) (Baqui et al. 2008 ) and the highest total fertility rate (4.2) in the country at the start of the study (NIPORT et al. 2005) . The district had poor access to health services and low utilization of skilled attendants at birth. To optimize the impact of the intervention, community meetings and household visits by CHWs were introduced to provide behaviour change communications, demonstrations to promote newborn care preparedness, and detection and management of serious illnesses. Attempts to measure morbidity were not undertaken in order to minimize the presence of CHWs in the community and their potential for impact and confounding of study results.
Disease categories and definitions
Preterm birth is defined as <37 weeks gestation. It is a component of LBW, defined as newborns weighing <2500 g who are either preterm and/or have intrauterine growth restriction. Very preterm was defined in this analysis as <33 weeks gestation, and late preterm as 33 to <37 weeks. Complications of preterm birth may comprise the greatest proportion of the direct morbidity and mortality of LBW infants, so disability weights for LBW were used as a proxy due to the current lack of disability weights for preterm. Current Child Health Epidemiology Reference Group (CHERG) and Global Burden of Disease (GBD) research is underway to estimate the burden of disease due to preterm. Studies for disability parameterization excluded those limited to cohorts of <28 weeks since these neonates are unlikely to survive in community-based settings in developing countries (Kuti and Owa 2003) , as confirmed in our data. Incidence and classification of preterm were derived from Projahnmo I data, with outcomes defined according to Khan et al. (2006) . Suspected clinical infections in Projahnmo I were identified according to a simplified version of the Integrated Management of Childhood Illness (IMCI) algorithm based on selection of seven clinical signs (Young Infants Clinical Signs Study Group Figure 1 Component trees describing the full model. Probabilities correspond to those for male neonates (female probabilities are similar). Terminal nodes are followed by disability weights / male life span / female life span (A) Root tree. (B) Preterm sequelae. In the reference case, these ten branches emanate from Nodes 1 & 2 (Khan et al. 2006) . In sensitivity analysis, weights for 15% treated (0.256) and 85% untreated (0.291) survivors are tested. Further sensitivity analysis tests a simple disability weight (0.110). (C) IPR-NE sequelae. In the reference case, the outcomes structure below emanates from Node 3 of the root tree. In sensitivity analysis, a simple disability weight emanates (0.374). (D) Meningitis sequelae emanating from Nodes 4-7 derived from (Edmond et al. 2010 2008). Relevant infections include neonatal sepsis, bacterial meningitis, pneumonia and viral infections; which are difficult to differentiate in community settings. All of these infections may result in chronic impairment depending on the pathogen, disease severity and its management; however, data were only available to consider meningitis Watt et al. 2009; Edmond et al. 2010) . Other conditions such as kernicterus were not included as jaundice outcomes research is only emerging (Gordon et al. 2005; Olusanya and Somefun 2009) . Diagnoses in the Projahnmo I trial were categorized as very severe disease (presence of certain single critical clinical signs), possible very severe disease (presence of multiple signs individually indicative of less severe disease) and possible very severe disease with only a single sign . The algorithm used has since been validated (Darmstadt et al. 2011) . Our definition of the proportion of suspected community-acquired infection included all three of these categories. The proportion of suspected infections that was meningitis was quantified across four high mortality countries (WHO Young Infants Study Group 1999), and survival and proportion and types of sequelae were defined according to a pooled estimate Watt et al. 2009; Edmond et al. 2010) .
Birth asphyxia was defined in Projahnmo I as not crying/ breathing, gasping and breathing slowly (<30/minute after birth). However, perinatal respiratory depression does not accurately predict long-term disability outcome and there has been advocacy for highlighting intrapartum events epidemiologically using more precise terminology (Lawn et al. 2005) . Intrapartum-related neonatal encephalopathy (IPR-NE) is a strong marker of those who will develop chronic disability and is used in this calculation (Lawn et al. 2009; Lawn et al. 2010; Lee et al. 2011a) . Incidence and sequelae parameterizations are based on updated GBD modelling and a previously published survival estimate from this work (Lawn et al. 2009 ).
Model structure
Potential disease outcomes were calculated through a tree framework ( Figure 1 ) excluding neonates with congenital anomalies or no condition, and not considering co-morbidity. This conceptual framework followed the pattern of incidence, post-neonatal survival and presence of sequelae; following the precedent of illness, death and disability used by the original national burden of disease exercise (Ghana Health Assessment Project Team 1981). Classification of sequelae was done according to proportions of each outcome used in the ABD study and two articles (Khan et al. 2006; Edmond et al. 2010) . Branches were divided by sex to account for minor differences in incidence and life expectancy. Methods for calculating probabilities at tree nodes with three branches ensured that all randomly generated sets summed to one (Sendi and Clemen 1999) . A time horizon including the lifespan of the neonate was assumed. Costs from a societal perspective and YLL components were derived from previous calculations.
YLD calculation
YLD were calculated based on the standard DALY component equation (WHO 2009 ). We used Bangladesh-specific life expectancies in the reference case scenario assuming constant disability from each condition for the lifetime of the neonate. Reductions in Bangladeshi life expectancy due to each sequela were set proportional to reductions used in the ABD, and preterm life expectancies were tested according to a scenario based on published assumptions (Profit et al. 2010) . The discount rate was set at 3% according to the WHO standard for economic evaluation of health interventions in LMICs (Tan-Torres Edejer et al. 2003). We excluded age weighting from the reference case as several arguments suggest that this level of complexity is not appropriate or necessary (Mathers et al. 2006b ), it makes little difference to results (Barendregt et al. 1996) and DCP2 practice is to exclude it (Musgrove and Fox-Rushby 2006) . We used Microsoft Excel to structure the calculation with a Visual Basic macro to perform Monte Carlo Simulations (1000 iterations), and evaluated model outputs with STATA 12 to generate regression coefficients for a tornado diagram (generated with 30 000 iterations to increase stability of results).
Disability weights
Disability weights from the ABD study based on Dutch Public Health Status and Forecast study values were used in the main calculation, with weights from the GBD study tested in sensitivity analysis (Murray and Lopez 1996) . Dutch weights were derived using a person trade-off ranking of disease stages with interpolation of others, and are the same construct as GBD weights (Mathers et al. 2006a) . GBD weights for LBW (applied to preterm in this analysis) and IPR-NE are listed in Table 1b with ranges of uncertainty (Mathers et al. 2006a ) and different values for treated and untreated forms of LBW (proxy for preterm) (Shibuya and Murray 1998a) . Derivation of Dutch weights has been described (Stouthard et al. 2000) , and the high degree of correlation between the Dutch and GBD studies has been demonstrated ).
Proportional differences between arms
Estimates of the difference between model arms were based on a variety of sources in the absence of specific data on disabilities across study arms or trial phases in Projahnmo I (Table 2b) . Consistent with an odds ratio of 0.51 pooled from four studies on the effectiveness of hand washing (Blencowe et al. 2011) , and a decline in incidence of infections by 48.2% from 1995-96 to 1997-98 in Gadchiroli India (CHW home-based management of neonatal infections) (Bang et al. 2005c) , 48.2% was used for incremental reduction in infection incidence. We assumed the overall mortality reduction from Projahnmo I to be mostly due to home-based neonatal sepsis recognition and antibiotic treatment; infection mortality was 28% lower in the intervention arm relative to the comparison arm in 2005 (Baqui et al. 2008 ). This figure was applied to model reduction in mortality due to infection. Incidence of IPR-NE was reduced by only 1% since only 5% of Projahnmo I births were attended and 20% of IPR-NE can be prevented in community settings (Darmstadt et al. 2009c; Lee et al. 2011b ). Bag-and-mask training was not included in Projahnmo I, although immediate stimulation through wiping and drying and mouth-to-mouth resuscitation were included. With low birth attendance in the community, and 12% hospital delivery in the home care arm (Baqui et al. 2009b) , we assumed any change in IPR-NE survival to be negligible. No reduction of preterm incidence was expected as preventive interventions for preterm were beyond the scope of Projahnmo I. Cause-specific mortality data from Projahnmo I suggest that the difference in preterm survival was not significant. Interventions to prevent and treat infections, preterm birth and intrapartum events are likely to reduce incidence and severity of long-term sequelae (IOM 2003; Anon 2009; Barros et al. 2010; Furyk et al. 2011) , but longitudinal studies that coincide with our defined outcomes in the Bangladeshi context are not currently available.
Sensitivity analysis
Our study modifies ABD calculations by incorporating Bangladesh-specific parameter definitions (Table 2a) , a tree structure and sensitivity analysis around each model probability. Beta distributions were used to represent parameter uncertainty, with upper and lower limits defined according to 95% confidence intervals (CIs), interquartile ranges or ranges derived from literature. Alpha and beta moments were derived from the mean and standard deviation of triangular distributions; defined according to best, low and high values from our data and literature search. Disability weights from the original GBD were tested in scenario analysis (Shibuya and Murray 1998a; Shibuya and Murray 1998b) , and the fraction of preterm patients treated was assumed to be 15%, consistent with the WHO assumption for treatment of LBW infants (Figure 1 ) (Murray and Lopez 1996) . The discount rate was tested at 0% and 6%, and age weighting was tested according to GBD precedent. Regional life expectancies were tested to be consistent with DCP2 evaluations. Global standard life expectancy was tested according to the West Life Table Level 26 (80  males, 82 .5 females) to enhance equity and make results comparable with GBD 2000 estimates (Coale and Demeney 1983; Lopez et al. 2006) . Sources for uncertainty around other parameters were drawn from those reviewed by the GBD project (Shibuya and Murray 1998a; Shibuya and Murray 1998b) , PubMed and internet searches, and review of bibliographies (Table 2a and 
Results
Incidence of the three major neonatal conditions in Projahnmo I were 18.0% (male) and 16.8% (female) for preterm birth (Projahnmo I), 15.9% (male) and 13.8% (female) for suspected clinical infection (Projahnmo I) and 1.34% for IPR-NE (Lawn et al. 2009 ). The sex ratio for preterm birth in Projahnmo I data (1.1) was lower than the 1.22 to 1.5 that is expected from published data (Cooperstock and Campbell 1996; Ingemarsson 2003 (Edmond et al. 2010) and 69% for infants with IPR-NE (Lawn et al. 2009 ). Sequelae resulted for 5% of late preterm infants (estimate), 68% for very preterm infants (Khan et al. 2006 ) and 9.5-34.7% for infants with meningitis. Forty per cent of infants with IPR-NE developed mild sequelae, and 30% developed moderate to severe sequelae (Lee et al. 2011a) . Before intervention, the full model predicted 22/1000 neonates having any preterm sequelae, 9/1000 having IPR-NE sequelae and <1/1000 having meningitis sequelae. The estimate for infection is likely low as only meningitis sequelae were considered due to lack of data on pneumonia, sepsis and viral infection from Southeast Asia. Furthermore, these numbers for 'sequelae' do not reflect morbidity severity or duration. The result for IPR-NE sequelae is similar to that found in Nepal (8/1000) (Lee et al. 2011a) and GBD project modelling (6/1000). These figures are not standard incidence calculations, but are products of 'rolling back' or taking the weighted average of parameters from each branch of the tree. When morbidity duration is accounted for, the proportional burden of disability is preterm (73%), IPR-NE (24%) and meningitis (3%) ( Table 3) . Proportions of more specific outcomes are given in Table 4. YLD expected for 1000 neonates are shown according to different DALY formula assumptions and sequelae branches (Table 3) . YLD changed as expected when different life expectancies were used, age-weighting was added and the discount rate was adjusted. Using 1998 GBD weights and the assumption that 85% of preterm patients remain untreated was similar to the reference case. In the simple analysis, while the weighted average of GBD weights and full life expectancies were greater than the weighted average of Dutch weights, we considered shorter life spans for very preterm in the simple analysis (GBD weights) according to a published single estimate (Profit et al. 2010) . The main analysis found more disability than the analysis using single disability weights for preterm, meningitis and IPR-NE because the weighted average for the preterm disability weights is higher. If years of healthy life are valued at per-capita Gross National Income (GNI) (CMH 2001) , $731 in Bangladesh (deflated from 2012 to 2010) (World Bank 2012), the resulting value of health losses is $142 940 per 1000 neonates.
One-way sensitivity analyses highlight the importance of parameters with wide ranges of uncertainty (IPR-NE incidence, percent very preterm sequelae), parameters proximal in the tree (preterm incidence, percent late preterm) and parameters with strong preceding nodes (percent late preterm sequelae) in influencing the YLD estimates (Table 5) . Infections parameters were not as influential given the low probability of survival and of sequelae among survivors. Overall, YLD increase with incidence, survival and sequelae. Results are confirmed by tornado diagrams that highlight the importance of IPR-NE and preterm incidence, percent of infections that are meningitis, being late preterm, or having very or late preterm sequelae (Figure 2 ). With all parameters set at their worst case scenario, YLD (3,0) per 1000 increase to 374 [719 for YLD (0,0)].
With assumed incremental reductions, our model predicts that 2.0 (95% CI 1.3-2.8) DALYs would be averted per 1000 neonates (Table 6a ). This disability is valued at $1427 (95% CI $933-$2037) per 1000 neonates. Applied to the original cost-effectiveness analysis, adding YLD leads to 0.6% additional DALYs averted and reduces the incremental cost-effectiveness ratio (ICER) from $105.23 to $104.62 ($65.15-$266.60) per DALY averted (Table 6b ).
Discussion
Calculated from YLD results, our analysis found a burden of morbidity equivalent to approximately 7 deaths per 1000 neonates after intervention [one death equals 28 discounted (3%) DALYs]. Preterm was the biggest contributor to the YLD count, despite most being late preterm with low probability of sequelae, as preterm has the highest incidence and survival. Few neonates develop IPR-NE and 31% die, but it contributes the second largest amount of YLD since 70% of survivors develop neurodevelopmental sequelae. Data are incomplete on outcomes from pneumonia, sepsis and viral infections, and meningitis accounts for the smallest amount of sequelae in our model. Reflecting correct DALY formulation, discounting had a strong effect on results, and age weighting had little effect. Adjusting life expectancy had the strongest effect when the West Life Table was tested with age weighting.
In the United States, 50% of neurological sequelae from neonatal conditions is due to preterm birth (Goldenberg and Culhane 2007) , which can be compared with the 73% predicted by our model. YLD per 1000 neonates were 142 for preterm, 48 for IPR-NE and 5 for meningitis; which together are higher than the YLD estimate for overall disability in Bangladesh from the WHO World Report on Disability (10.1/100 people) (WHO 2011). ABD calculations found 7 YLD for LBW, 3 for IPR-NE and 1 for infection per 1000 neonates. Bangladesh has a higher incidence of preterm births (17.4% in Projahnmo I, compared with 6.5% for LBW in Australia) (WHO 2004 ), but has a slightly lower probability that these infants will survive to develop sequelae. More YLD were incurred due to infection in Bangladesh than Australia because incidence and sequelae were more prevalent in Bangladesh (sequelae were seen in 2.71% of the total population compared with 0.9% in Australia). Overall, both improved survival and neurodevelopmental outcomes may be expected in all but the most premature neonates as quality and access to care improve through time (Vohr et al. 2005; Wilson-Costello et al. 2007; Roberts et al. 2010) . Externally validated to other developing country settings, preterm incidence in the Projahnmo I dataset (17.4%) was higher than the incidence reported for south central Asia, at 11.4% (10.0-12.7) (Beck et al. 2010) , although this is consistent with other studies from Bangladesh (Al Mamun et al. 2006; Arifeen et al. 2000) . IPR-NE incidence estimates applied to our model are less than 'asphyxia' incidence estimates from Africa (3-26.5/1000) (Tafari 1985; Airede 1991a; Airede 1991b ) and CHERG modelling (18.6/1000) (Lee et al. 2011c) . The incidence of community-acquired meningitis among neonates presenting to health facilities in four high mortality countries in the Young Infants Study Group was 3.4% (WHO Young Infants Study Group 1999) is higher than the laboratory-confirmed community-based estimate of infection from Bangladesh (0.29%) assessed by CHWs (Darmstadt et al. 2009b) .
The model structure is relevant to comparable settings in Southeast Asia and sub-Saharan Africa (SSA); however, many published studies in Africa are hospital-based and less useful for community-based parameters (Hodgson et al. 2001; Klingenberg et al. 2003) . Some exceptions exist (Hinderaker et al. 2003) , and community-based programmes are established in Pakistan and India, which have similar demographic and epidemiologic trends to Bangladesh. Further programmes are developing in Ethiopia, Malawi and Tanzania where national neonatal mortality rates are comparable. Data from these and other clinical trials may inform parameters, although long-term outcomes are difficult to measure (Villar and Shah 2004) .
Optimally, impairment from 'asphyxia' may be measured epidemiologically according to IPR-NE definitions, although this is not possible for most community settings. New tools are available, which have been validated for use in identifying disabilities at the population level in children under 2 years (Khan et al. 2010; Khan et al. 2012) . These tools have the potential to advance our ability to measure the burden of disabilities and impairments in the community.
A non-systematic review of literature was performed to establish ranges of uncertainty according to published sources relevant to the context, which was limited by a scarcity of Bangladeshi data. In generalizing to other settings, incidence estimates may be confounded by socio-economic, health system, cultural, ethnic, environmental or genetic factors. Ways in which these factors can have an effect include access and care-seeking at health services, unsafe traditional practices, unawareness of beneficial health practices, suspicion of care providers perceived as outsiders, limited geographic mobility, and epidemiological patterns such as the increasing incidence of preterm birth (Lawn et al. 2010) .
There are several limitations of this analysis. Data are difficult to collect in LMICs as many births do not have a qualified attendant present. In Projahnmo I, 5% of births were attended, particularly relevant for evaluating IPR-NE (although since then the proportion of neonates that receive a visit from a village health worker within 24 hours after birth has improved to 87%) (Shah et al. 2010) . Where a complete lack of evidence exists from Bangladesh, data were used from a multi-country trial, pooled estimates or GBD parameterizations. Longitudinal studies varied in their follow-up times which may indicate administrative censoring, and outcomes occur with low frequency in the population, adding to uncertainty in estimates.
Variation between impairment assessments was substantial and data quality was inconsistent, thus comparing articles defining limits for sensitivity analysis was necessarily roughdifferent outcome variables were measured, using different tools, defined at different thresholds, tested at different ages and including different sample cohorts. Different diagnostic algorithms were used in Projahnmo I and the Young Infants Study Group; the latter may have been less specific since it included infants that the mother or health worker thought were ill generally (Young Infants Clinical Signs Study Group 2008) . Data on all relevant infections is incomplete, and survival and sequelae parameterization was based solely on meningitis outcomes (Edmond et al. 2010) . Studies in the infections arm reported outcomes for children under 5 Watt et al. 2009; Edmond et al. 2010) , not neonates, which we assume would be more severe. Follow-up times were variable (most sequelae will present within 2 years) (Marlow 2004) . Different sample cohorts came from hospital and community-based settings.
While this model uses discrete definitions, it is not always possible to delineate clearly the boundaries between different neonatal conditions, particularly in the context of disaggregating 'birth asphyxia' from infection (Shibuya and Murray 1998a) . Each of the three disease categories share clinical symptoms and are 
MODELLING NEONATAL DISABILITY IN BANGLADESH risk factors for each of the others (except IPR-NE as a risk factor for preterm). All three conditions lead to similar long-term outcomes including functional limitations, cognitive and behavioural deficits, seizure and severe hearing loss. It is difficult to distinguish an intrapartum etiology for IPR-NE in community settings (Nelson and Leviton 1991) , although verbal autopsy instruments exist for distinguishing between risk factors. Several IPR-NE symptoms are difficult to assess (Darmstadt et al. 2009a) , and agreement on definition is undergoing evolution (Halloran et al. 2009; Lawn et al. 2009 ). Methods are developing to cross-check community-based data based on computer algorithms and expert review to improve identification of 'birth asphyxia' in the community setting , and the proportion of institutional deliveries may be expected to increase as programmes develop. Diagnostic algorithms for infections are non-specific in community settings where health workers of minimal training cannot distinguish sepsis, meningitis and pneumonia from each other or various conditions with overlapping clinical signs, and which frequently coexist. Even for qualified providers, separate algorithms for preterm, infection and 'birth asphyxia' have been poorly validated (Weber et al. 2003; Lee et al. 2008) .
Improvements in algorithm diagnosis of infection have since been made for sepsis (Baqui et al. 2009c ) and neurodevelopmental status (Khan et al. 2010) . Preterm is usually defined based on time since last menstrual period, or a clinical assessment (Beck et al. 2010) , although clinical assessments (Dubowitz and Ballard scores) can be too complex for community settings. Last menstrual period has been shown to be relatively accurate in various settings, only slightly overestimating age (depending on quality of measurement) (Rosenberg et al. 2009) , with wider uncertainty among populations with lower education levels. Substituting preterm for LBW may be more problematic for incidence and sequelae than mortality because almost all LBW neonatal deaths are preterm .
Some relevant conditions were not included such as intra-uterine growth restriction (IUGR) and congenital anomalies. IUGR incidence in Bangladesh was found to be 65% in Dhaka slums (Arifeen et al. 2000) , although mortality evidence from Bangladesh is limited to a doctoral research project (SE Arifeen, Johns Hopkins University) and further research is needed (Walker et al. 2007 ). The CHERG is generating further data, and a crude odds ratio suggests that IUGR neonates may be at risk of developmental deficits, although this relationship is not significant when adjusted for confounders (Wu et al. 2011) . While it has a 60.3% prevalence in Nepal (Wu et al. 2011) , IUGR is less prevalent in African settings (Manji 2009 ). The impact of malaria on preterm (Menendez et al. 2000; Ngassa 2000) , neonatal outcomes among HIV infected women (Fawzi et al. 2000; Mehta et al. 2008) and bacterial resistance to antibiotics may be additional considerations. For congenital anomalies, only a few preventive or curative interventions exist in the developing country setting (such as folic acid during pregnancy, micronutrient supplementation, and nutritional and substance abuse counselling). The burden of congenital anomalies is being estimated in forthcoming work by WHO/ CHERG, emphasizing neural tube defects, heart conditions and chromosomal abnormalities.
Current incidence data are defined according to single conditions. Co-morbidities would reduce incidence in single-condition branches, and occur frequently in Bangladesh (Khan et al. 2006) . Survival in co-morbidity branches is likely to be lower than single condition branches (Bang et al. 2005d) , the probability of sequelae would be higher, and disability weights would be higher. Co-morbidity data from Gadchiroli, India exist (Bang et al. 2005e; Bang et al. 2005a ) and some relevant Dutch disability weights are available (Stouthard et al. 1997) , although work is needed to develop relevant disability weights in a Southeast Asian setting. Since co-morbidity is not considered, YLD results are likely to be biased; neonates cannot die twice and resulting disability is unlikely to be additive. Evidence is needed for other outcomes; for example preterm birth, neonatal infection and IPR-NE can all lead to epilepsy. Disability weights should be developed for speech delays and mild behavioural and learning conditions (Khan et al. 2006) . Proportional differences between model arms are based on the best available evidence. Incidence of suspected clinical infection was only measured in one trial arm of Projahnmo I, IPR-NE evidence is not available, and the validity and precision of other evidence is limited due to low birth attendance. Interventions to address neonatal health conditions are reviewed in detail (Darmstadt et al. 2005; Lawn et al. 2006; Lawn et al. 2009; Wall et al. 2009; Barros et al. 2010) , and investigating their expected effectiveness is advocated where access to perinatal services is limited. However, care is not always provided in the home, neonatal conditions do not necessarily stimulate care seeking, and improvements to the burden of disease are likely to vary across locations.
Uncertainty around disability weights is being evaluated in the forthcoming version of the GBD study (GBD 2008) , which will allow for a more complete stochastic analysis. Disability weights for preterm are forthcoming in the current GBD project (WHO 2010) . The Dutch Public Health Status and Forecast study also provides disability weights for very preterm [0.52 (0.446-0.574)], and ranges of uncertainty around estimates for the conditions it included (Stouthard et al. 1997) , although it is not clear what disability weight to use for late preterm. A 3% discount rate reflects preferences of programme funders, and is WHO standard (Tan-Torres Edejer et al. 2003); however, people in poverty have more uncertainty about the future, and may value it less, making a 6-7% discount rate more representative of a local perspective (Robberstad 2005) . Recognizing the use of high discount rates in other sectors (Harrison 2010) , the implications of using them are that long-term health outcomes in developing countries will be valued less, which goes against the objectives of relevant programmes and analysts.
Ongoing research initiatives may address gaps in data, particularly proportional differences between model arms and long-term outcomes. Extrapolation from developed country trends can inform future forecasting as Bangladesh transitions from a high mortality setting and the relative importance of different conditions changes (Tafari 1985; Dunn 1986 ). The neonatal mortality rate in Bangladesh has declined by 17% in the last decade from 36 to 30 (UNICEF 2009), down from 41-42 in the late 1990s (NIPORT et al. 2005) . Disability weights may differ over life course, such as for Down's syndrome (Stouthard et al. 1997) , and taking that into account would require a Markov model rather than a decision tree. Evidence is mixed whether at-risk and disabled neonates can overcome disability, achieve academically at least equivalent to their peers, and successfully integrate into society (Marlow 2004; Maulik and Darmstadt 2009 ). Preterm and normal term people report similar values for quality of life (Saigal et al. 2006; Gäddlin et al. 2009; Baumgardt et al. 2012) , and parents' valuations of preterm conditions are usually higher than those of clinicians (Saigal et al. 1999) .
While disability is not explicitly mentioned in the Millennium Development Goals (Groce and Trani 2009) , results are relevant through the United Nations Convention on the Rights of Persons with Disabilities (CRPD) (UN 2007) . Also, the World Report on Disability was recently released (WHO 2011), and disability is a current focus of the CHERG (CHERG 2008) . Research suggests a link between infectious disease and intelligence at the national level (Eppig et al. 2010) , and long-term sequelae from neonatal conditions is a priority at the Gates Foundation, which is currently conducting a survey of newborns in Dar es Salaam (Manji 2009 ). The burden of disease results from this study may be of interest to several groups, and care is needed to ensure that the correct skill mix of health workers and professionals is available to maintain or reduce levels of disability in Sylhet, Bangladesh (Ahmed et al. 2011) .
Conclusions
Based on Australian and Global Burden of Disease precedent, our model quantifies the burden of disease resulting from neonatal conditions. It suggests that the burden of neonatal disability in Sylhet, Bangladesh is significant, particularly for preterm birth, with little effect on the interpretation of the cost-effectiveness of the community-based intervention. Quantifying burden of disease can be useful to help identify emerging trends and future needs, determine priorities for expenditure, provide information to educate the public, identify which interventions will have the greatest effect, help set research agendas (Hyder and Morrow 2006) , break policy inertia that results from lack of information, and to help programme managers monitor and improve the effectiveness of programmes. Studies examining IPR-NE incidence and longitudinal studies examining the sequelae of all three disease categories in LMICs are needed to improve precision of results and to consider new settings. Based on current evidence, health decision-makers should implement CHW programmes in similar settings and expect a small but significant decrease in morbidity.
Acknowledgements
Theo Vos provided valuable feedback at the design stage of the analysis. Emma Williams, Heather Rosen and Luke Mullany Funding
